Neomycin fixation followed by ethanol pretreatment leads to reduced buckling and inhibition of calcification in bioprosthetic valves

Journal of Biomedical Materials Research - Part B Applied Biomaterials

Volumn 92, Issue 1, 2010, Pages 168-177

  Raghavan, Devanathan ^a   Shah, Sagar R ^a   Vyavahare, Naren R ^a  

^a AMRL   (United States)

Author keywords

Calcification; Extracellular matrix; Fixation; Heart valve; Implant design

Indexed keywords

BIOPROSTHESES; BIOPROSTHETIC HEART VALVES; CALCIFICATION POTENTIAL; CO-EXISTENCE; CROSSLINKED; ENZYMATIC DEGRADATION; ETHANOL PRETREATMENT; ETHANOL TREATMENT; EXTRACELLULAR MATRICES; EXTRACELLULAR MATRIX COMPONENTS; GLUTARALDEHYDES; GLYCOSAMINOGLYCANS; HEART VALVES; IMPLANT DESIGN; IN-VITRO; IN-VIVO; IN-VIVO CALCIFICATION; LITTLE RESEARCH; MATRIX; MATRIX FAILURE; SODIUM BOROHYDRIDES;

ALDEHYDES; ANTIBIOTICS; BONE; ETHANOL; SODIUM; VALVES (MECHANICAL);

BIOMINERALIZATION;

ALCOHOL; ALDEHYDE; GLUTARALDEHYDE; GLYCOSAMINOGLYCAN; NEOMYCIN; SODIUM BOROHYDRIDE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BIOPROSTHESIS; CALCIFICATION; CONTROLLED STUDY; ENZYME ACTIVITY; EXTRACELLULAR MATRIX; IN VITRO STUDY; IN VIVO STUDY; INHIBITION KINETICS; MALE; NONHUMAN; RAT;

ANIMALS; BIOPROSTHESIS; CALCINOSIS; COLLAGEN; COLLAGENASES; ETHANOL; GLYCOSAMINOGLYCANS; HEART VALVE PROSTHESIS; NEOMYCIN; PANCREATIC ELASTASE; RATS; SWINE;

EID: 74749104912     PISSN: 15524973     EISSN: 15524981     Source Type: Journal    
DOI: 10.1002/jbm.b.31503     Document Type: Article

References (43)

1. Raghavan D, Simionescu DT, Vyavahare NR. Neomycin prevents enzyme-mediated glycosaminoglycan degradation in bioprosthetic heart valves. Biomaterials 2007;28:2861-2868.
2. Shah SR, Vyavahare NR. The effect of glycosaminoglycan stabilization on tissue buckling in bioprosthetic heart valves. Biomaterials 2008;29:1645-1653.
3. Schoen FJ, Levy RJ. Founder's Award, 25th Annual Meeting of the Society for Biomaterials, Perspectives. Providence, RI, April 28-May 2, 1999. Tissue heart valves: Current challenges and future research perspectives. J Biomed Mater Res 1999;47:439-465.
4. Schoen FJ, Levy RJ. Calcification of tissue heart valve substitutes: Progress toward understanding and prevention. Ann Thorac Surg 2005;79:1072-1080.
5. Gott JP, Pan C, Dorsey LM, Jay JL, Jett GK, Schoen FJ, Girardot JM, Guyton RA. Calcification of porcine valves: A successful new method of antimineralization. Ann Thorac Surg 1992;53:207-215; discussion 16.
6. Simionescu DT. Artificial heart valves. In: Akay M, Hoboken NJ, editors. Wiley's Encyclopedia of Biomedical Engineering. New York: John Wiley and Sons, Inc.; 2006.
7. Zilla P, Bezuidenhout D, Human P. Carbodiimide treatment dramatically potentiates the anticalcific effect of alpha-amino oleic acid on glutaraldehyde-fixed aortic wall tissue. Ann Thorac Surg 2005;79:905-910.
8. Vyavahare N. Preventing bioprosthetic heart valve calcification: Are we there yet? Perspect Cardiac Surg 2005;2:5-12.
9. Zilla P, Bezuidenhout D, Weissenstein C, van der Walt A, Human P. Diamine extension of glutaraldehyde crosslinks mitigates bioprosthetic aortic wall calcification in the sheep model. J Biomed Mater Res 2001;56:56-64.
10. Zilla P, Human P, Bezuidenhout D. Bioprosthetic heart valves: The need for a quantum leap. Biotechnol Appl Biochem 2004;40:57-66.
11. Connolly JM, Alferiev I, Kronsteiner A, Lu Z, Levy RJ. Ethanol inhibition of porcine bioprosthetic heart valve cusp calcification is enhanced by reduction with sodium borohydride. J Heart Valve Dis 2004;13:487-493.
12. Tagliaferro P, Tandler CJ, Ramos AJ, Pecci Saavedra J, Brusco A. Immunofluorescence and glutaraldehyde fixation. A new procedure based on the Schiff-quenching method. J Neurosci Methods 1997;77:191-197.
13. Eike JH, Palmer AF. Effect of NaBH4 concentration and reaction time on physical properties of glutaraldehyde-polymerized hemoglobin. Biotechnol Prog 2004;20:946-952.
14. Clancy B, Cauller LJ. Reduction of background autofluorescence in brain sections following immersion in sodium borohydride. J Neurosci Methods 1998;83:97-102.
15. Elson LA, Morgan WT. A colorimetric method for the determination of glucosamine and chondrosamine. Biochem J 1933;27:1824-1828.
16. Isenburg JC, Karamchandani NV, Simionescu DT, Vyavahare NR. Structural requirements for stabilization of vascular elastin by polyphenolic tannins. Biomaterials 2006;27:3645-3651.
17. Isenburg JC, Simionescu DT, Vyavahare NR. Elastin stabilization in cardiovascular implants: Improved resistance to enzymatic degradation by treatment with tannic acid. Biomaterials 2004;25:3293-3302.
18. Isenburg JC, Simionescu DT, Vyavahare NR. Tannic acid treatment enhances biostability and reduces calcification of glutaraldehyde fixed aortic wall. Biomaterials 2005;26:1237-1245.
19. Lovekamp JJ, Simionescu DT, Mercuri JJ, Zubiate B, Sacks MS, Vyavahare NR. Stability and function of glycosaminoglycans in porcine bioprosthetic heart valves. Biomaterials 2006;27:1507-1518.
20. Mercuri JJ, Lovekamp JJ, Simionescu DT, Vyavahare NR. Glycosaminoglycan-targeted fixation for improved bioprosthetic heart valve stabilization. Biomaterials 2007;28:496-503.
21. Pieper JS, Oosterhof A, Dijkstra PJ, Veerkamp JH, van Kuppevelt TH. Preparation and characterization of porous crosslinked collagenous matrices containing bioavailable chondroitin sulfate. Biomaterials 1999;20:847-858.
22. Vesely I, Boughner D, Song T. Tissue buckling as a mechanism of bioprosthetic valve failure. Ann Thorac Surg 1988;46:302-308.
23. Vesely I, Mako WJ. Comparison of the compressive buckling of porcine aortic valve cusps and bovine pericardium. J Heart Valve Dis 1998;7:34-39.
24. Raghavan D, Starcher BC, Vyavahare NR. Neomycin binding preserves extracellular matrix in bioprosthetic heart valves during in vitro cyclic fatigue and storage. Acta Biomater 2009;5:983-992.
25. Grunkemeier GL, Jamieson WR, Miller DC, Starr A. Actuarial versus actual risk of porcine structural valve deterioration. J Thorac Cardiovasc Surg 1994;108:709-718.
26. Vesely I, Barber JE, Ratliff NB. Tissue damage and calcification may be independent mechanisms of bioprosthetic heart valve failure. J Heart Valve Dis 2001;10:471-477.
27. Flameng W, Meuris B, Yperman J, De Visscher G, Herijgers P, Verbeken E. Factors influencing calcification of cardiac bioprostheses in adolescent sheep. J Thorac Cardiovasc Surg 2006;132:89-98.
28. Wells SM, Sellaro T, Sacks MS. Cyclic loading response of bioprosthetic heart valves: Effects of fixation stress state on the collagen fiber architecture. Biomaterials 2005;26:2611-2619.
29. Simionescu DT, Lovekamp JJ, Vyavahare NR. Extracellular matrix degrading enzymes are active in porcine stentless aortic bioprosthetic heart valves. J Biomed Mater Res A 2003;66:755-763.
30. Simionescu DT, Lovekamp JJ, Vyavahare NR. Degeneration of bioprosthetic heart valve cusp and wall tissues is initiated during tissue preparation: An ultrastructural study. J Heart Valve Dis 2003;12:226-234.
31. Simionescu DT, Lovekamp JJ, Vyavahare NR. Glycosaminoglycan-degrading enzymes in porcine aortic heart valves: Implications for bioprosthetic heart valve degeneration. J Heart Valve Dis 2003;12:217-225.
32. Lee CH, Vyavahare N, Zand R, Kruth H, Schoen FJ, Bianco R, Levy RJ. Inhibition of aortic wall calcification in bioprosthetic heart valves by ethanol pretreatment: Biochemical and biophysical mechanisms. J Biomed Mater Res 1998;42:30-37.
33. Levy RJ, Vyavahare N, Ogle M, Ashworth P, Bianco R, Schoen FJ. Inhibition of cusp and aortic wall calcification in ethanol- and aluminum-treated bioprosthetic heart valves in sheep: Background, mechanisms, and synergism. J Heart Valve Dis 2003;12:209-216; discussion 16.
34. Vyavahare N, Hirsch D, Lerner E, Baskin JZ, Schoen FJ, Bianco R, Kruth HS, Zand R, Levy RJ. Prevention of bioprosthetic heart valve calcification by ethanol preincubation. Efficacy and mechanisms. Circulation 1997;95:479-488.
35. Vyavahare NR, Hirsch D, Lerner E, Baskin JZ, Zand R, Schoen FJ, Levy RJ. Prevention of calcification of glutaraldehyde-crosslinked porcine aortic cusps by ethanol preincubation: Mechanistic studies of protein structure and water-biomaterial relationships. J Biomed Mater Res 1998;40:577-585.
36. Vyavahare NR, Jones PL, Hirsch D, Schoen FJ, Levy RJ. Prevention of glutaraldehyde-fixed bioprosthetic heart valve calcification by alcohol pretreatment: Further mechanistic studies. J Heart Valve Dis 2000;9:561-566.
37. Lee TC, Midura RJ, Hascall VC, Vesely I. The effect of elastin damage on the mechanics of the aortic valve. J Biomech 2001;34:203-210.
38. Nimni ME, Myers D, Ertl D, Han B. Factors which affect the calcification of tissue-derived bioprostheses. J Biomed Mater Res 1997;35:531-537.
39. Weissenstein C, Human P, Bezuidenhout D, Zilla P. Glutaraldehyde detoxification in addition to enhanced amine crosslinking dramatically reduces bioprosthetic tissue calcification in the rat model. J Heart Valve Dis 2000;9:230-240.
40. Arenaz B, Maestro MM, Fernandez P, Turnay J, Olmo N, Senen J, Mur JG, Lizarbe MA, Jorge-Herrero E. Effects of periodate and chondroitin 4-sulfate on proteoglycan stabilization of ostrich pericardium. Inhibition of calcification in subcutaneous implants in rats. Biomaterials 2004;25:3359-3368.
41. Vanwachem PB, Vanluyn MJA, Damink LHHO, Dijkstra PJ, Feijen J, Nieuwenhuis P. Biocompatibility and tissue regenerating capacity of cross-linked dermal sheep collagen. J Biomed Mater Res 1994;28:353-363.
42. Zilla P, Brink J, Human P, Bezuidenhout D. Prosthetic heart valves: Catering for the few. Biomaterials 2008;29:385-406.
43. Thubrikar MJ, Skinner JR, Eppink RT, Nolan SP. Stress analysis of porcine bioprosthetic heart valves in vivo. J Biomed Mater Res 1982;16:811-826.